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Abstract
Fifty-three children who attended the emergency department with community-associated (CA) Staphylococcus aureus skin and soft tissue
infections (SSTIs) were enrolled in the study. Seven cases of infection (13.2%) were due to methicillin-resistant S. aureus (MRSA).
Twelve of 46 available isolates (26.1%) were Panton–Valentine leukocidin (PVL)-positive. PVL-positive S. aureus SSTIs were more
frequently associated with abscesses and cellulitis (75% vs. 38%, p 0.028), and more commonly required incision and drainage (75% vs.
21%, p 0.001). Most PVL-positive CA-MRSA isolates belonged to a single multilocus sequence type (ST8). In contrast, PVL-positive
methicillin-susceptible S. aureus isolates belonged to four different sequence types (ST8, ST30, ST80, ST120).
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) was con-
ﬁned to hospitals until 1982, when it was ﬁrst described
among drug users [1]. In Spain, the ﬁrst case of MRSA infec-
tion was reported in 1981 [2]. In 1998, community-associ-
ated (CA)-MRSA emerged as a pathogen in children when
four deaths were reported [3]. CA-MRSA is predominately
associated with skin and soft tissue infections (SSTIs) that
are most commonly mild, but which can also develop into
deep-seated lesions that require emergency care or hospital-
ization [4].
Although increased prevalence of CA-MRSA among chil-
dren has been reported in the USA, few such studies have
been documented in Europe [5–7]. In a multicentre investiga-
tion, Panton–Valentine leukocidin (PVL), a two-component
pore-forming cytotoxin associated with S. aureus causing
furuncles and necrotizing pneumonia, was detected in 98% of
MRSA isolates and 42% of methicillin-susceptible S. aureus
(MSSA) isolates from CA SSTIs [8,9]. After detecting the
emergence of a single clone of CA-MRSA among children at
our hospital, we decided to conduct a prospective study to
determine (i) the prevalence of CA-MRSA among children
with SSTIs who were treated in the emergency department,
(ii) the frequency with which PVL genes are present in CA
S. aureus SSTIs, and (iii) the epidemiological and molecular
characteristics of CA S. aureus infections.
Materials and Methods
This study was conducted at the Hospital Universitario 12
de Octubre, a 1300-bed tertiary-care facility that comprises
two separate buildings, one for children (176 beds) and the
other for adults. This public hospital provides specialized
healthcare to a population of approximately 550 000 resi-
dents in southern Madrid, Spain. The number of children
treated at the children emergency department during 2007
was 67 861. From January to December of 2007, we con-
ducted a prospective study in which we enrolled children
<15 years of age who attended the emergency department
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of the Hospital Universitario 12 de Octubre and who were
diagnosed with CA S. aureus SSTIs. Patient data were
collected on a standardized form. Among the patients admit-
ted to hospital, S. aureus isolates were considered to be
community-associated if there were no predisposing factors
for healthcare-acquired infection, such as underlying disease
(e.g. cystic ﬁbrosis, chronic renal failure, history of malig-
nancy, immunodeﬁciency, asthma, or chronic skin illness),
previous hospitalization or surgical procedures within the
past year (excluding healthy newborns), or the presence of
any indwelling catheter or percutaneous medical device.
Bacterial identiﬁcation and antimicrobial susceptibility test-
ing were performed with Wider panels (Soria-Melguizo,
Madrid, Spain) [10], based on the broth microdilution
method, and were interpreted using the CLSI criteria [11].
Susceptibility tests were carried out with penicillin, oxacillin,
ciproﬂoxacin, gentamicin, erythromycin, clindamycin, trimeth-
oprim-sulfamethoxazole, vancomycin, teicoplanin and linezo-
lid. All S. aureus isolates underwent PCR analysis for the
mecA gene [12]. The presence of PVL genes (lukS-PV and
lukF-PV) was also determined by PCR [8]. Macrorestriction
analysis of SmaI-digested chromosomal DNA was performed
in all MRSA and PVL-positive MSSA [13]. Additionally, MRSA
isolates underwent staphylococcal cassette chromosome mec
(SCCmec) characterization using PCR [12]. All PVL-positive
MSSA and all MRSA were characterized by multilocus
sequence typing (MLST) as described previously [14]. The
attending physicians remained blind to the molecular test
results until the end of the study.
Univariate analysis was performed using the t-test for con-
tinuous variables and the v2 or Fisher’s exact test for cate-
gorical variables. Statistical analysis of the data was
performed with Epi-Info (CDC, Atlanta, GA, USA) and SPSS
(SPSS Inc., Chicago, IL, USA) software.
Results
A total of 53 children with CA S. aureus SSTIs were enrolled
from among the attendees of the emergency department.
The median age was 42 months (range 1–174) and 37 (70%)
were boys. Fifty-one percent of the children had parents of
Spanish origin, whereas 49% had parents who were born
abroad. Seven of the 53 infections (13%) were attributed to
CA-MRSA. Infections were classiﬁed into three groups: 31
(59%) were superﬁcial (impetigo, folliculitis), 17 (32%) were
associated with cellulitis and abscesses, and ﬁve (9.4%) were
deep-seated. Seventeen (32%) of the patients were admitted
to the hospital and 16 (30%) required incision and drainage.
No statistically signiﬁcant differences were found between
children with MRSA and MSSA with regard to age [median
24 months (range 12–174) vs. 44 months (range 1–174);
p 0.752], male sex (86% vs. 67%, p 0.661), type of infection
(abscesses and cellulitis, 57% vs. 39%, p 0.431), or admission
to hospital (43% vs. 30%, p 0.667). Nonetheless, the propor-
tion of children whose parents were from Ecuador was
higher in the MRSA group (4/7, 57%) than in the MSSA
group (5/46, 11%) (p 0.012).
Isolates from 46 children (seven MRSA and 39 MSSA)
were available for further molecular characterization. Of
these, 12 (26%) were PVL-positive. The comparison between
PVL-positive and -negative S. aureus infections showed that
both groups were similar in age, proportion of male sex and
those of Ecuadorian parentage, and proportion admitted to
hospital (Table 1). In contrast, PVL-positive S. aureus SSTIs
were more frequently associated with abscesses and cellulitis
(75% vs. 38%, p 0.028), more commonly required incision
and drainage (75% vs. 21%, p 0.001), and more frequently
were methicillin-resistant (42% vs. 5.9%, p 0.009) (Table 1).
We repeated this analysis by removing the seven MRSA
cases, and still found that cases of PVL-positive MSSA SSTIs
more frequently required surgical intervention with incision
and drainage than cases due to PVL-negative organisms (71%
vs. 23%, p 0.022).
All MRSA isolates were susceptible to all the antibiotics
tested, except for the b-lactams. Six of seven (86%) PVL-
positive MSSA isolates were susceptible to all antibiotics
tested, whereas the remaining isolate was resistant to genta-
micin. Pulsed-ﬁeld gel electrophoresis (PFGE) analysis of
seven MRSA isolates showed that six (86%) exhibited the
same PFGE pattern (Fig. 1). Results from MLST and SCCmec
typing showed that this common MRSA pattern belonged to
ST8 SCCmec type IV.
Five of the ST8 SCCmec type IV isolates were PVL-posi-
tive and one was PVL-negative. Four of the PVL-positive
MRSA isolates were from children of Ecuadorian parentage
TABLE 1. Characteristics of the children with Panton–
Valentine leukocidin (PVL)-positive and PVL-negative
Staphylococcus aureus infections
Characteristic
PVL-positive
(n = 12)
PVL-negative
(n = 34) p
Age (months)
Median 28 55 0.879
Range 8–174 1–160
Male 10 (83%) 23 (68%) 0.461
Origin of parent
from Ecuador
4 (33%) 4 (13%) 0.178
Type of infection
(cellulitis, abscesses)
9 (75%) 13 (38%) 0.028
MRSA 5 (42%) 2 (6%) 0.009
Hospital admission 6 (50%) 11 (32%) 0.314
Incision and drainage 9 (75%) 7 (21%) 0.001
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and one was from a Spanish-born child. The remaining
PVL-negative MRSA isolate, obtained from a Bulgarian boy,
belonged to ST34 and could not be typed by SCCmec analy-
sis even when a second PCR strategy was used [15]. PFGE
analysis of seven PVL-positive MSSA isolates showed at least
ﬁve different macrorestriction patterns belonging to four
MLST types: ST30 (three isolates), ST120 (two isolates), ST8
(one isolate), and ST80 (one isolate) (Fig. 1).
Discussion
We identiﬁed a high incidence of CA-MRSA (13%) among
children with S. aureus SSTIs who were treated in the emer-
gency department during 2007, despite the fact that CA-
MRSA in children was reported for the ﬁrst time in Madrid
only in 2006 [6]. In the year prior to this study, MRSA was
detected in <1% of children who attended the emergency
department (data not shown). Nevertheless, the prevalence
of CA-MRSA at our institution is still far below that
reported elsewhere, where the proportion of CA-MRSA
infections may be as high as 74% [4].
Because most of the MRSA isolates in this study belonged
to a single MLST-SCCmec clone (ST8 SCCmec type IV) and
are therefore likely to share a common ancestry with the
USA300 strain that is widespread in the USA [16], our
results may represent an early warning of the emergence of
CA-MRSA in Spain. Noteworthy is that four of the MRSA
isolates, all of which were of the same PFGE, MLST and
SCCmec types, were recovered from unrelated children, all
of whom have Ecuadorian parents. Other studies in Spain
have detected the emergence of CA-MRSA clones in patients
from Ecuador [17]. Although we have no data about the pre-
valent clones of MRSA in Ecuador, immigration to Spain has
increased sharply in the last few years and might explain the
appearance of this new clone in Madrid. An important obser-
vation was that the PVL-positive MLST lineages causing
CA-MSSA infections (ST30, ST80 and ST8) were the same as
those reported in other countries [18]. These MSSA clones
are probably circulating in the community and could be the
parental reservoir for the development of common
CA-MRSA strains through the acquisition of SCCmec and
other resistance determinants. More extensive studies are
necessary to understand the respective contributions
of immigration and genetic evolution to increased rates of
CA-MRSA infection.
Although our study was of limited size, an important ﬁnd-
ing was that children with CA PVL-positive S. aureus SSTIs
were more likely to have severe local disease and require
incision and drainage. Even when CA-MRSA infections were
removed from the analysis, and only the CA-MSSA SSTIs
were included, PVL-positive MSSA SSTIs still required more
frequent surgical intervention. It is important to note that
the decision to treat with incision and drainage was made
prior to the availability of the molecular test results to the
physician. Although recent animal studies comparing the viru-
lence and lethality of PVL-positive and isogenic PVL-negative
MRSA strains have produced conﬂicting results [19,20], clini-
cal studies have found the presence of PVL genes to be asso-
ciated with enhanced inﬂammatory response and local
disease [21,22]. A recent study also identiﬁed novel cytolytic
peptides as key virulence determinants for CA-MRSA [23].
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FIG. 1. Pulsed-ﬁeld gel electrophoresis and
multilocus sequence types of 14 methicillin-
resistant (MRSA) and methicillin-susceptible
Staphylococcus aureus (MSSA) isolates from
children with community-associated skin and
soft tissue infections. Lane M, k molecular
weight marker; lanes 1–7 represent MRSA
isolates [1 and 2 Panton–Valentine leukocidin
(PVL)-negative, and 3–7 PVL-positive]; lanes
8–14 represent PVL-positive MSSA isolates.
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Additional studies are needed to determine the involvement
of PVL in CA S. aureus infections and whether the detection
of PVL genes or other toxin genes might be useful for
patient management and infection control.
Although culture and antimicrobial susceptibility testing
have not been a routine component of SSTI management,
the emergence of CA-MRSA indicates a need to modify this
practice. It is also important to investigate all possible reser-
voirs and transmission pathways as a means to improve
infection control. Importation of new clones by displaced
populations has worldwide implications for the epidemiology
of MRSA, and we believe that regular monitoring of children
for CA-MRSA is critical in helping to predict and mitigate
the spread of the corresponding infections.
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